Cresset Asset Management’s Innoviva INVA Stock Holding History

Cresset Asset Management’s Portfolio INVA Stock Details INVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-13,828	Closed	-$238K	–	1059
2021 Q4	$238K	Buy	+13,828	New	+$236K	﹤0.01%	976
2019 Q2	–	Sell	-27	Closed	–	–	1040
2019 Q1	$0	Sell	27 -74	-73%	-$1.2K	﹤0.01%	2042
2018 Q4	$2K	Buy	+101	New	+$1.64K	﹤0.01%	1321

Other funds holding INVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Cresset Asset Management's INVA Position: Q1 2022 in Review

Cresset Asset Management sold out of Innoviva (INVA) in Q1 2022, closing a stake of 13,828 shares — an estimated $238K sold.

Cresset Asset Management first reported a position in INVA in Q4 2018 and held it in 3 quarters. The position peaked at $238K in Q4 2021. 236 funds tracked by Wall St. Rank hold INVA as of Q1 2022.

Cresset Asset Management reported no remaining Innoviva position as of Q1 2022 after selling out during the quarter.
Cresset Asset Management sold 13,828 Innoviva shares in Q1 2022, an estimated $238K.
Cresset Asset Management first reported a position in Innoviva in Q4 2018 and held it in 3 quarters.
Cresset Asset Management's Innoviva position peaked at $238K in Q4 2021.
236 funds tracked by Wall St. Rank held Innoviva as of Q1 2022.

Based on Cresset Asset Management's 13F filing for Q1 2022, filed 16 May 2022.